Similar articles

• New Insulins, Biosimilars, and Insulin Therapy.

  Danne T, Heinemann L, Bolinder J. Danne T, et al. Diabetes Technol Ther. 2017 Feb;19(S1):S42-S58. doi: 10.1089/dia.2017.2505. Diabetes Technol Ther. 2017. PMID: 28192016 Review. No abstract available.
• Novel and Emerging Insulin Preparations for Type 2 Diabetes.

  Cheung KK, Alexander P Sr. Cheung KK, et al. Can J Diabetes. 2015 Dec;39 Suppl 5:S160-6. doi: 10.1016/j.jcjd.2015.09.082. Can J Diabetes. 2015. PMID: 26653255 No abstract available.
• Cardiovascular Safety of Current and Emerging Glucose-Lowering Therapies.

  Fitchett D. Fitchett D. Can J Diabetes. 2015 Dec;39 Suppl 5:S176-82. doi: 10.1016/j.jcjd.2015.09.083. Can J Diabetes. 2015. PMID: 26654861 No abstract available.
• Insulin Pumps.

  Pickup JC. Pickup JC. Diabetes Technol Ther. 2017 Feb;19(S1):S19-S26. doi: 10.1089/dia.2017.2503. Diabetes Technol Ther. 2017. PMID: 28192024 Review. No abstract available.
• NMDAR antagonists for the treatment of diabetes mellitus-Current status and future directions.

  Welters A, Klüppel C, Mrugala J, Wörmeyer L, Meissner T, Mayatepek E, Heiss C, Eberhard D, Lammert E. Welters A, et al. Diabetes Obes Metab. 2017 Sep;19 Suppl 1:95-106. doi: 10.1111/dom.13017. Diabetes Obes Metab. 2017. PMID: 28880473 Review.